Protective role for club cell secretory protein-16 (CC16) in the development of COPD

European Respiratory Journal

Volumn 45, Issue 6, 2015, Pages 1544-1556

  Laucho Contreras, Maria E ^a   Polverino, Francesca ^a,b,c   Gupta, Kushagra ^a   Taylor, Katherine L ^a   Kelly, Emer ^a   Pinto Plata, Victor ^a,b   Divo, Miguel ^a   Ashfaq, Naveed ^a   Petersen, Hans ^b   Stripp, Barry ^d   Pilon, Aprile L ^e   Tesfaigzi, Yohannes ^b   Celli, Bartolome R ^a,b   Owen, Caroline A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PARMA   (Italy)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e Clarassance Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; CLUB CELL SECRETORY PROTEIN 16; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCIN 5AC; SECRETORY PROTEIN; UNCLASSIFIED DRUG; CASP3 PROTEIN, MOUSE; CASPASE 3; CYP2F2 PROTEIN, MOUSE; CYTOCHROME P450; MUC5AC PROTEIN, MOUSE; SCGB1A1 PROTEIN, HUMAN; SCGB1A1 PROTEIN, MOUSE; SECRETORY PHOSPHOLIPASE A2; SMOKE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UTEROGLOBIN;

ADULT; AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKE-INDUCED EMPHYSEMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS CELL; LUNG COMPLIANCE; LUNG FUNCTION; MOUSE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOKING; ANIMAL; CASE CONTROL STUDY; CYTOLOGY; GENE TARGETING; GENETICS; KNOCKOUT MOUSE; LUNG; LUNG ALVEOLUS; LUNG EMPHYSEMA; LUNG FUNCTION TEST; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SMOKE; TOBACCO;

AIRWAY REMODELING; ANIMALS; APOPTOSIS; CASE-CONTROL STUDIES; CASPASE 3; CYTOCHROME P-450 ENZYME SYSTEM; GENE KNOCK-IN TECHNIQUES; HUMANS; LUNG; MICE; MICE, KNOCKOUT; MUCIN 5AC; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHOLIPASES A2, SECRETORY; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS; SMOKE; SMOKING; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TOBACCO; UTEROGLOBIN;

EID: 84930412299     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00134214     Document Type: Article

References (40)

1. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013; 369: 448-457.
2. Owen CA. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008; 3: 253-268.
3. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
4. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365: 1184-1192.
5. Casanova C, de Torres JP, Aguirre-Jaime A, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med 2011; 184: 1015-1021.
6. Nishimura M, Makita H, Nagai K, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 44-52.
7. Lomas DA, Silverman EK, Edwards LD, et al. Evaluation of Serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 2008; 63: 1058-1063.
8. Park HY, Churg A, Wright JL, et al. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 188: 1413-1419.
9. Stripp BR, Reynolds SD, Boe IM, et al. Clara cell secretory protein deficiency alters Clara cell secretory apparatus and the protein composition of airway lining fluid. Am J Respir Cell Mol Biol 2002; 27: 170-178.
10. Dodge DE, Rucker RB, Pinkerton KE, et al. Dose-dependent tolerance to ozone. III. Elevation of intracellular Clara cell 10-KDa protein in Central Acini of rats exposed for 20 months. Toxicol Appl Pharmacol 1994; 127: 109-123.
11. Chen LC, Zhang Z, Myers AC, et al. Cutting edge: altered pulmonary eosinophilic inflammation in mice deficient for Clara cell secretory 10-KDa protein. J Immunol 2001; 167: 3025-3028.
12. Wang SZ, Rosenberger CL, Bao YX, et al. Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection. J Immunol 2003; 171: 1051-1060.
13. Bernard AM, Roels HA, Buchet JP, et al. Serum Clara cell protein: an indicator of bronchial cell dysfunction caused by tobacco smoking. Environ Res 1994; 66: 96-104.
14. Laing IA, Hermans C, Bernard A, et al. Association between plasma CC16 levels, the A38G polymorphism, and asthma. Am J Respir Crit Care Med 2000; 161: 124-127.
15. Mattsson J, Remberger M, Andersson O, et al. Decreased serum levels of Clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation. Transplantation 2005; 79: 1411-1416.
16. Chen J, Lam S, Pilon A, McWilliams A, et al. The association between the anti-inflammatory protein CC10 and smoking status among participants in a chemoprevention trial. Cancer Epidemiol Biomarkers Prev 2007; 16: 577-583.
17. Chen J, Lam S, Pilon A, et al. Higher levels of the anti-inflammatory protein CC10 are associated with improvement in bronchial dysplasia and sputum cytometric assessment in individuals at high risk for lung cancer. Clin Cancer Res 2008; 14: 1590-1597.
18. Berger RL, Celli BR, Meneghetti AL, et al. Limitations of randomized clinical trials for evaluating emerging operations: the case of lung volume reduction surgery. Ann Thorac Surg 2001; 72: 649-657.
19. Stripp BR, Lund J, Mango GW, et al. Clara cell secretory protein: a determinant of PCB bioaccumulation in mammals. Am J Physiol 1996; 271: L656-L664.
20. Long XB, Hu S, Wang N, et al. Clara cell 10-KDa protein gene transfection inhibits NF-KappaB activity in airway epithelial cells. PLoS ONE 2012; 7: e35960.
21. Andersson O, Nordlund-Moller L, Barnes HJ, et al. Heterologous expression of human uteroglobin/polychlorinated biphenyl-binding protein. Determination of ligand binding parameters and mechanism of phospholipase A2 inhibition in vitro. J Biol Chem 1994; 269: 19081-19087.
22. Gagliardo R, Chanez P, Profita M, et al. IkappaB kinase-driven nuclear factor-KappaB activation in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2011; 128: 635-645.
23. Pilette C, Godding V, Kiss R, et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 185-194.
24. Adair-Kirk TL, Atkinson JJ, Griffin GL, et al. Distal airways in mice exposed to cigarette smoke: Nrf2-regulated genes are increased in Clara cells. Am J Respir Cell Mol Biol 2008; 39: 400-411.
25. Plopper CG, Cranz DL, Kemp L, et al. Immunohistochemical demonstration of cytochrome P-450 monooxygenase in Clara cells throughout the tracheobronchial airways of the rabbit. Exp Lung Res 1987; 13: 59-68.
26. Van Winkle LS, Johnson ZA, Nishio SJ, et al. Early events in naphthalene-induced acute Clara cell toxicity: comparison of membrane permeability and ultrastructure. Am J Respir Cell Mol Biol 1999; 21: 44-53.
27. Kim DK, Cho MH, Hersh CP, et al. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 1238-1247.
28. Buro-Auriemma LJ, Salit J, Hackett NR, et al. Cigarette smoking induces small airway epithelial epigenetic changes with corresponding modulation of gene expression. Hum Mol Genet 2013; 22: 4726-4738.
29. Johansson S, Andersson K, Wennergren G, et al. CC16 inhibits the migration of eosinophils towards the formyl peptide FMLF but not towards PGD2. Inflammation 2009; 32: 65-69.
30. Zhang Z, Kim SJ, Chowdhury B, et al. Interaction of uteroglobin with lipocalin-1 receptor suppresses cancer cell motility and invasion. Gene 2006; 369: 66-71.
31. Burmeister R, Boe IM, Nykjaer A, et al. A two-receptor pathway for catabolism of Clara cell secretory protein in the kidney. J Biol Chem 2001; 276: 13295-13301.
32. Snyder JC, Reynolds SD, Hollingsworth JW, et al. Clara cells attenuate the inflammatory response through regulation of macrophage behavior. Am J Respir Cell Mol Biol 2010; 42: 161-171.
33. Pniewska E, Pawliczak R. The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease. Mediators Inflamm 2013; 2013: 793505.
34. Churg A, Zhou S, Wang X, et al. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 2009; 40: 482-490.
35. Churg A, Marshall CV, Sin DD, et al. Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 34-43.
36. Churg A, Wang R, Wang X, et al. Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in Guinea pigs. Thorax 2007; 62: 706-713.
37. Reynolds SD, Mango GW, Gelein R, et al. Normal function and lack of fibronectin accumulation in kidneys of Clara cell secretory protein/uteroglobin deficient mice. Am J Kidney Dis 1999; 33: 541-551.
38. Zheng F, Kundu GC, Zhang Z, et al. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice. Nat Med 1999; 5: 1018-1025.
39. Zhang Z, Kundu GC, Yuan CJ, et al. Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science 1997; 276: 1408-1412.
40. Hagen G, Wolf M, Katyal SL, et al. Tissue-specific expression, hormonal regulation and 5'-flanking gene region of the rat Clara cell 10 KDa protein: comparison to rabbit uteroglobin. Nucleic Acids Res 1990; 18: 2939-2946.